Marker Therapeutics Inc (NASDAQ: MRKR) stock closed at $3.04 on 9/3/24 after a major decline of -15.8%. Moreover, this decline was accompanied by exceptionally high trading volume at 217% of normal. The stock has performed in line with the market over the last nine months and has declined -17.1% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. Marker Therapeutics has a slightly negative Power Rating of 39 and a very low Appreciation Score of 8, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment